BonaliveInc
$3.3K 34 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Meitheal Pharmaceuticals, Inc.
Meitheal Pharmaceuticals, Inc. reported $3,347.67 across General Payments, Research, and Ownership to 9 physicians and teaching hospitals across 9 transactions.
- $3.3K Below-median payer
- All-tracks total
- 9 Below-median volume
- Transactions
- 9 Below-median reach
- Recipients
- #1757
- of 1,925 companies
Meitheal Pharmaceuticals, Inc. reported $3,347.67 across all CMS Open Payments tracks (General + Research + Ownership) to 9 physicians and teaching hospitals in Program Year 2024 - ranking #1757 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,347.67, averaging $371.96 per recipient.
Meitheal Pharmaceuticals, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer meitheal-pharmaceuticals-inc Meitheal Pharmaceuticals, Inc.
$3.3K · #1757/1,925 · 0.0% industry · PY2024
- TOT $3.3K
- RANK #1757
- SHARE 0.0%
- TXN 9
- RCP 9
- CAT 2
- GEN $3.3K
- TOP1 24.8%
- PY 2024
Volume peers
Nearest volume peer: BonaliveInc ($3.3K)
Meitheal Pharmaceuticals, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Meitheal Pharmaceuticals, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Meitheal Pharmaceuticals, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
4 transactions worth $3.0K make "Honoraria" the top general-payment category in the 2-category breakdown below, 89.6% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, Meitheal Pharmaceuticals, Inc.'s largest category was "Honoraria" at $3.0K - 89.6% of General Payments.
How Meitheal Pharmaceuticals, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $3.0K | 4 | 89.6% |
| Food and Beverage | $347.67 | 5 | 10.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $3,347.67 (100.0%) of $3,347.67 in this company's General Payments records across 5 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Meitheal Pharmaceuticals, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Jose Vazquez
$830.19 across 2 reported transactions
- 2
Andrew Shorr
$830.19 across 2 reported transactions
- 3
Yoav Golan
$830.19 across 2 reported transactions
- 4
Cornelius Clancy
$830.19 across 2 reported transactions
- 5
Allison Rodgers
$26.91 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Meitheal Pharmaceuticals, Inc. ranks #1757 of 1,925 by total payments (bottom 9% by spend) but is notably more concentrated than that alone would suggest -- #659 of 1,838 by HHI (top 36% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Agfa HealthCare Corporation : $400.9K total payments, HHI 2487
- Zap Surgical Systems, Inc. : $43.0K total payments, HHI 2486
- VisionRT, Inc. : $6.9K total payments, HHI 2476
- Ventana Medical Systems, Inc. : $655.4K total payments, HHI 2476
- Lumendi LLC : $164.6K total payments, HHI 2475
- Shalby Advanced Technologies, Inc. : $120.5K total payments, HHI 2474
- Meitheal Pharmaceuticals, Inc. (this company) : $3.3K total payments, HHI 2461
- Naviswiss, Inc. : $48.9K total payments, HHI 2455
- ParaPRO, LLC : $38.8K total payments, HHI 2454
- The Binding Site Inc. : $5.0K total payments, HHI 2452
- Johnson & Johnson Health Care Systems Inc. : $2.7M total payments, HHI 2444
- Bluewind Medical : $570.9K total payments, HHI 2436
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Meitheal Pharmaceuticals, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Meitheal Pharmaceuticals, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Meitheal Pharmaceuticals, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Northern X-Ray Company
$3.3K 2 recipients
Compare payment profiles
Pillar Biosciences, Inc
$3.3K 8 recipients
Compare payment profiles
Xiros Inc
$3.4K 4 recipients
Compare payment profiles
Lifeward, Inc.
$3.4K 58 recipients
Compare payment profiles
Intersurgical Inc
$3.3K 2 recipients
Compare payment profiles
Put this to use
Meitheal Pharmaceuticals, Inc. ranks #1757 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just Meitheal Pharmaceuticals, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.